precision medicine

The partners will develop a database for academics and biopharma researchers to acquire insights to help advance cancer-focused research.

At HIMSS23, panelists discussed how genomics could improve patient care and the challenges to implementing genetic testing programs.

Dr. Cecil Lynch, chief medical information officer at Accenture, discusses his upcoming HIMSS23 lecture on genomics' potential impact on patient care and the importance of examining genetic information and its relationship to comorbidities.

A look ahead with Judy Jiao, CIO of National Government Services, who also gives insights on precision medicine advancements and more.

The consortium's collaboration and partnership opportunities may be the most beneficial to the HIMSS audience, according to James Hury, the Translational Research Institute for Space Health's chief innovation officer.

Dr. Maulik Purohit, clinical innovation lead for transformation at University Hospitals, examines tech strategies and the unique challenges of clinical genetics and pop health genomics.

CEO and cofounder of InsightRX Sirj Goswami shares how precise dosage, determined for each patient, can improve healthcare and avoid unwanted outcomes.

2bPrecise CEO Assaf Halevy discusses how genomic information can be injected into the workflow to manage the treatment of the patient.

The health research platform has already helped enroll 356,000 participants into the nationwide research program.

The roughly three-year-old company says it now has a post-money valuation over $1 billion.